An Evaluation of the Effectiveness and Acceptability of Delivering Structured Care in Chinese Type 2 Diabetic Patients
NCT01360697 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4800
Last updated 2015-08-03
Summary
In this demonstration project (JADE in Jiangsu \& Anhui Program, JADE-JA in short) led by key opinion leaders in the field of diabetes and endocrinology in Jiangsu and Anhui area and supported by the ADF, shall recruit 4800 type 2 diabetic patients attending medical out-patient clinics in the area to compare the effects of usual versus structured care (non-JADE vs JADE) on metabolic control, quality of life and behavioral changes. After explanation by trained doctors and nurses and with written informed consent, patients will be randomized to either the JADE or non-JADE group. The former encompasses all components of the structured care delivered by a trio-team of doctor, nurse and Healthcare Assistant (HCA) while the non-JADE group only consists of comprehensive assessments (CA) at baseline and 12-month with patients managed in the usual manner thereafter. At the end of 12 months, all patients will undergo repeat comprehensive assessments for comparison of rates of attainment of treatment targets, behavioral changes, quality of life and default rates. The acceptability of the JADE-JA Program by patients and the trio-team will also be evaluated.
The investigators hypothesize that the use of state of the art information technology to record, manage and analyze the large amount of clinical information generated during various consultation visits will improve the effectiveness and efficiency in implementing these care protocols through decision support and regular feedback to both patients and care team.
Conditions
Interventions
- OTHER
-
JADE
1. The nurse will complete the CA using standardized protocol including blood \& urine tests, eye \& feet examination. 2. Whenever feasible, the nurse will arrange 2-4 hours of diabetes education in groups or on an individual basis as appropriate. 3. Between each follow-up (FU) visit, the nurse or HCA will contact the patient by phone or email to remind them to attend visits, adhere to medications \& healthy lifestyles, perform self blood glucose monitoring as appropriate. 4. At each FU visit, the patients will first see the nurse or HCA for record of blood pressure, body weight \& blood glucose (or A1c) measurement as appropriate. Compliance will also be checked using the 4-item questionnaire. 5. After the FU visit, the patients will see the nurse or HCA again to clarify any issues \& concerns, reinforce compliance \& record any changes in medications. 6. After each FU visit, the HCA will generate summary reports to be given to patients \& doctors to promote sharing of information.
- OTHER
-
Non-JADE
Patients will receive a comprehensive assessments at baseline and again after 12 months. In the interim between these two time points patients will be managed according to 'usual care' procedures.
Sponsors & Collaborators
-
Asia Diabetes Foundation
lead OTHER
Principal Investigators
-
Juliana Chan, MD · Asia Diabetes Foundation
-
Gary Ko, MD · Asia Diabetes Foundation
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-05-31
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- China
Study Locations
More Related Trials
-
Comprehensive Awareness and Control in Diabetes Patients in China Jiangxi: A Cross-Sectional Survey
NCT03363360 ·Status: UNKNOWN
-
A Prospective Study on Diabetes Management Through an Integrated Delivery System
NCT00288678 ·Status: COMPLETED ·Phase: PHASE3
-
Hypertension and Diabetes Mellitus Community Management Center(HAD-COME) Project
NCT04229628 ·Status: UNKNOWN
-
Chinese Endocrinologists Health Education Study
NCT05715307 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effects of Shared Medical Appointments for Diabetic Patients in Taiwan
NCT06032429 ·Status: COMPLETED ·Phase: NA
-
The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) Program
NCT03503942 ·Status: COMPLETED ·Phase: NA
-
The Effect of Remote SMBG Combined With the Application of APP on the Improvement of T2DM Management in the Community
NCT03588000 ·Status: COMPLETED ·Phase: NA
-
Collaborative Care Model on Type 2 Diabetic Patients
NCT03553862 ·Status: COMPLETED ·Phase: NA
-
Study on the Feasibility of Community Doctors Guided by Specialists to Use Basic Insulin
NCT04553380 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Share Care Model in the Improvement of Diabetes Management
NCT03707379 ·Status: RECRUITING
-
Evaluation and Intervention of Cognitive Function in Patients With Diabetes Mellitus.
NCT05262257 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Comprehensive Longitudinal Cohort Study in Type 2 Diabetes With High Risk of Cardiovascular Diseases in China
NCT01307410 ·Status: UNKNOWN
-
TCM and Nutrition for Diabetes Care Cohort
NCT05312450 ·Status: COMPLETED
-
Endovascular Denervation (EDN) for the Treatment of Type 2 Diabetes Mellitus
NCT05673668 ·Status: UNKNOWN ·Phase: NA
-
China Diabetes Registry by Metabolic Management Center
NCT03811470 ·Status: RECRUITING
-
Diabetes Care Programme for Type 2 Diabetes Mellitus in Primary Care Setting
NCT04348565 ·Status: UNKNOWN ·Phase: NA
-
DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Setting in Japan
NCT02226822 ·Status: COMPLETED
-
A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Thailand
NCT00805922 ·Status: COMPLETED
-
Endovascular Denervation for the Treatment of Type 2 Diabetes Mellitus
NCT05631561 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Multifactorial Intervention on Diabetes (MIDiab Study)
NCT03430284 ·Status: UNKNOWN ·Phase: PHASE4
-
A Comparison of European and Chinese Blood Sugar Responses
NCT02577874 ·Status: UNKNOWN
-
Comparing the Clinical Characteristics of Male LADA, T1DM and T2DM Patients
NCT04618354 ·Status: COMPLETED
-
Cohort Study in Type 2 Diabetes in China
NCT01076023 ·Status: UNKNOWN
-
HbA1c Prediction Model in Patients With Type 2 Diabetes
NCT05824286 ·Status: UNKNOWN ·Phase: NA
-
The Effects of add-on Anti-diabetic Drugs in Type 2 Diabetic Patients
NCT02885922 ·Status: UNKNOWN